News Focus
News Focus
Followers 58
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

Re: georgejjl post# 256509

Saturday, 06/27/2020 10:25:19 AM

Saturday, June 27, 2020 10:25:19 AM

Post# of 515616

Please, confirm the following statement of mine.



Top-line results from the Anavex PDD trial should be very easy and quick to analyze using computerized statistical analysis programs that are commercially available.



This stands out to me as an opportunity for complete evaluation and system validation according to a plan and protocol acceptable to an informed body/regulatory body. So, get this validated for the intended purpose first.

I have confidence in results which can be directly measured and which are reproducible.

I would have confidence is our ability to do this motion testing/motor scores.

MDS-UPDRS Part III Total Score (Motor Scores) [ Time Frame: 14 weeks ]
Change from baseline to End of Treatment as measured by MDS-UPDRS Part III Total Score (Motor Scores)

https://clinicaltrials.gov/ct2/show/NCT03774459

BTW, if Dr.M. has established this criteria and AVXL capability to do proper V&V, then I have confidence also.

WE are not BIIB, it is what it is. The results must be consistent and reproducible.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News